Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$6.02 USD
+0.01 (0.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.00 -0.02 (-0.33%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.63 |
Last EPS Surprise | -16.67% |
ABR | 1.45 |
Earnings ESP
|
-5.30% |
---|---|
Current Year | -1.89 |
Next Year | -1.71 |
EPS (TTM) | -2.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 504.80M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 999.00M |
Low Estimate | NA | NA | NA | 10.60M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.47 | -1.89 | -1.71 |
# of Estimates | 6 | 6 | 6 | 5 |
Most Recent Consensus | -0.52 | -0.52 | -2.12 | -2.35 |
High Estimate | -0.37 | -0.33 | -1.38 | -1.39 |
Low Estimate | -0.55 | -0.53 | -2.16 | -2.35 |
Year ago EPS | -0.54 | -0.59 | -2.42 | -1.89 |
Year over Year Growth Est. | 7.41% | 20.34% | 21.90% | 9.49% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.47 | -1.89 | -1.71 |
7 Days Ago | -0.50 | -0.47 | -1.89 | -1.71 |
30 Days Ago | -0.50 | -0.46 | -1.87 | -1.65 |
60 Days Ago | -0.50 | -0.46 | -1.87 | -1.64 |
90 Days Ago | -0.55 | -0.53 | -2.13 | -1.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -0.48 | -1.99 | -1.97 |
Zacks Consensus Estimate | -0.50 | -0.47 | -1.89 | -1.71 |
Earnings ESP | -5.30% | -2.86% | -5.11% | -14.94% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.63 | -0.64 | -0.59 | -0.54 | NA |
Estimate | -0.54 | -0.50 | -0.53 | -0.58 | NA |
Difference | -0.09 | -0.14 | -0.06 | 0.04 | -0.06 |
Surprise | -16.67% | -28.00% | -11.32% | 6.90% | -12.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more